Properties of Mammalian Methylenetetrahydrofolate Reductase
The conversion of homocysteine to methionine requires a sequence of three enzymatic reactions, which are catalyzed by serine hydroxymethyltransferase (4-1), methylenetetrahydrofolate reductase (MTHFR ), and cobalamin-dependent methionine synthase (4-3), respectively. 
The combined action of these three enzymes results in the methylation of homocysteine by transfer of a methyl group derived from the β-carbon of serine. Methionine can be converted to adenosylmethionine (AdoMet) by adenosylmethionine synthetase, as shown in (4) . AdoMet is an activated methyl donor, and serves to provide methyl groups in a wide variety of biological methylation reactions.
Methionine + ATP → AdoMet + tripolyphosphate (4)
Methylenetetrahydrofolate reductase has been purified from a variety of bacterial and mammalian sources and has been shown to contain enzyme-bound FAD as a prosthetic group [1] [2] [3] [4] [5] [6] . The flavin plays an essential role in the catalytic reaction. In the porcine enzyme, which has been purified to homogeneity [6] and extensively studied, NADPH stoichiometrically reduces the flavin as indicated in (5) .
This reaction is irreversible both in vivo and in vitro [7] , and imparts irreversibility to the entire reaction shown in (2) . In the physiologic reaction, the reduced enzyme-bound flavin is oxidized by methylenetetrahydrofolate (CH 2 -H 4 folate) in a reaction that is freely reversible [6] , as shown in (6) .
The reversibility of the reaction shown in (6) has been exploited in the standard assay for MTHFR [1, 2, 5] Stereochemical and kinetic analyses of the reactions catalyzed by the porcine enzyme have shown that both NADPH and CH 2 -H 4 folate react at the si face of the enzyme-bound flavin [8] , which is depicted in Figure 1 . While X-ray structures have been determined for a variety of NADPH-dependent flavoprotein oxidoreductases [9] [10] [11] , the majority of these proteins bind one or more of their substrates at the re face of the flavin [12] . Thus, the sequence motifs that have been identified in these proteins as being associated with flavin binding may not be the same for MTHFR.
Kutzbach and Stokstad [5] initially demonstrated that mammalian MTHFR activity is regulated by the AdoMet/adenosylhomocysteine ratio, with AdoMet inhibiting enzyme activity and inhibition being relieved by adenosylhomocysteine. Thus, the activity of MTHFR is adjusted in accord with the demand for methyl groups for biological methylation reactions. AdoMet binding to MTHFR results in a conformational change to a form of enzyme with decreased affinity for NADPH. NADPH and AdoMet play antagonistic roles in this regulation, with NADPH recruiting the active forms of the enzyme, and AdoMet recruiting inactive forms [13] .
The native porcine MTHFR is a homodimer of 77 kDa subunits, but when shadowed preparations of the individual dimers are viewed in the scanning transmission electron microscope they show four clear lobes of density, rather than two [14] . These observations suggested that each subunit might contain two distinct regions. Limited proteolysis of the native enzyme with trypsin indeed results in cleavage of the 7 7 kDa subunit into 40 and 37 kDa fragments, and cleavage is associated with the loss of inhibition by AdoMet, but the activity of the enzyme is unaffected [14] . Photoaffinity labeling of the enzyme with 8-azido-S-adenosylmethionine results in specific labeling of the C-terminal 37 kDa region [15] .
The isolation of a cDNA coding for the human MTHFR and its recent sequencing [16, 17] have provided considerable insight into the organization of the enzyme. The deduced amino acid sequence for this cDNA is shown in Figure 2 , and corresponds to a molecular mass of 74,546 kDa. Underlined in Figure 2 are residues corresponding to peptides isolated from homogeneous porcine enzyme and sequenced by Edman degradation. The N-terminal sequence of the porcine enzyme does not appear in the human cDNA, which may indicate that the cDNA isolated codes for a smaller isozyme of MTHFR or perhaps lacks sequence at the 5′-end.
In one experiment, the native porcine enzyme was first digested with trypsin and the N-and C-terminal fragments were separated by gel electrophoresis under denaturing conditions. The isolated fragments were cleaved with lysyl endoprotease (LysC), which cleaves the amide bond on the C-terminal side of lysyl residues. Peptides that were derived from the 40 kDa Nterminal fragment correspond to residues 61-94, 219-240, and 337-351 [16] , while peptides that were derived from the 37 kDa C-terminal fragment correspond to residues 374-394, 420-445, 469-492, 531-543, and 598-628 (JS Sumner and RG Matthews, unpublished data). These sequences define the cleavage point between the 40 and 37 kDa fragments as lying between residues 351 and 374. The sequence in this region with the greatest hydrophilicity and surface probability is K357RREED, and this is the probable site of cleavage of the native enzyme. The predicted mass of the C-terminal fragment generated by cleavage between lysine357 and arginine358 is 34,863 Da, in moderately good agreement with the 37 kDa mass observed after cleavage of the porcine enzyme. 
Properties of the Bacterial Methylenetetrahydrofolate Reductase Enzymes
Figure 2 also shows the alignment of the deduced amino acid sequence of human MTHFR with the sequences of the methylenetetrahydrofolate reductases from Escherichia coli and Salmonella typhimurium. These aligned sequences show 24% identity, so that the threedimensional structures of the bacterial enzymes and the N-terminal region of the human enzyme are almost certainly highly similar. The MTHFR from Escherichia coli was initially characterized by Buchanan and his colleagues [3] . This enzyme was shown to be a flavoprotein, and was shown to catalyze the reduction of CH 2 -H 4 folate to CH 3 -H 4 folate. In contrast to the mammalian enzymes, the bacterial enzyme activity is not Figure 2 . Alignment of the deduced amino-acid sequence of human methylenetetrahydrofolate reductase [16, 17] , designated mthfr, with the deduced amino acid sequences of the MetF proteins from E. coli [19] and S. typhimurium [20] , designated ecometF and stymetF, respectively. Underlined residues indicate identities with residues in peptides isolated from porcine liver methylenetetrahydrofolate reductase. Residues shown in bold are identical in all three deduced sequences. Bullets indicate the locations of three mutations that are associated with homocysteinemia in humans and that affect conserved residues in the aligned sequences. The numbering of the mthfr amino acid sequence assumes that the ATG codon in the cDNA beginning at nt 13 of the published sequence [16] is the initiator site for translation of the protein.
regulated by adenosylmethionine, in agreement with the lack of a C-terminal regulatory domain. This protein is encoded by the metF gene in both E. coli and S. typhimurium. The metF gene from both organisms has been sequenced [19, 20] . We have succeeded in constructing an expression vector for overproduction of MTHFR from Escherichia coli plasmid pEJ3-1B, which contains the metF gene in a pBR322 plasmid [20] . In our vector, pCAS-5, the MTHFR coding sequence is placed under the control of the trc promoter, and approximately 20% of the total cellular protein is MTHFR when cells are grown in the presence of IPTG. We have recently purified the wild type bacterial enzyme to homogeneity, and have confirmed that the MTHFR protein is a flavoprotein. The homogenous enzyme exhibits both CH 3 -H 4 folate-menadione oxidoreductase activity (7), CH 3 -H 4 folate + menadione → CH 2 -H 4 folate + menadiol (7) and NADH-menadione oxidoreductase activity (8) .
Initial studies of partially purified MTHFR enzyme had indicated that NADH could supply reducing equivalents for the reduction of CH 2 -H 4 folate, but further purification of the enzyme by Katzen and Buchanan resulted in the loss of NADH-CH 2 -H 4 folate oxidoreductase activity [3] . However, in our enzyme preparations NADH-menadione oxidoreductase activity copurifies with CH 3 -H 4 folate-menadione oxidoreductase activity, and we presume that the physiologic reaction is given by (9) . NADH + CH 2 -H 4 folate → NAD + + CH 3 -H 4 folate (9) Thus, the bacterial enzymes are able to bind FAD and catalyze the transfer of reducing equivalents from NADH to the enzyme-bound flavin and from reduced flavin to CH 2 -H 4 folate. Since these enzymes are only ~33kDa (296 amino acids), the corresponding region of the human enzyme is likely to contain the residues necessary for FAD, NADPH, and CH 2 -H 4 folate binding. Thus the catalytic domain of the human enzyme is probably located in the N-terminal 40kDa region, while regulation by AdoMet is likely to require the C-terminal domain. The sequence alignment indicates several highly conserved regions of sequence, which are likely to contain residues critical to the binding of substrates and FAD, and to catalysis of oxidoreduction of the substrates.
Mutations Associated with Homocysteinemia in Humans and the Phenotypes of the Corresponding Bacterial Mutations
A number of mutations of human MTHFR that are associated with human disease have now been identified [16, 17, 21] . A subset of these mutations affect residues that are identical in the sequences of the bacterial enzymes aligned in Figure 2 . These mutations include Arg157Gln [16] and Thr227Met, as well as the polymorphism Ala222Val. In humans, the Thr227Met mutation in a homozygous state is associated with extremely low levels of activity (0-3%) and onset of symptoms within the first year after birth [21] . Thus far, the only patients with the Arg157Gln mutation are heterozygotes, with an uncharacterized second mutation [16, 21] . These patients have >6% residual activity and develop symptoms only during or after the second decade of life.
The Ala222Val polymorphism is thought to be associated with mild homocysteinemia in humans [17] . Homocysteinemia has been identified as an independent risk factor for cardiovascular disease [22] . Indeed, Kang and his colleagues [23] have described the association of a mild MTHFR deficiency, with increased thermolability, with increased risk for coronary artery disease. At the time this work was published, the sequence of MTHFR was not known, and so the mutation(s) responsible for this phenotype could not be not identified. Because the catalytic mechanism and tertiary structure of the N-terminal region of the human enzyme is likely to be very similar to those of the bacterial enzymes, we have undertaken the construction and expression of mutations that correspond to Arg157Gln, Thr227Met, and Ala222 Val in the E. coli enzyme. Characterization of these mutant enzymes is now in progress.
